safety analysis
Showing 9976 - 10000 of >10,000
Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,
Recruiting
- Relapsed/Refractory Follicular Lymphoma
- Marginal Zone Lymphoma (MZL)
- Odronextamab
- +2 more
-
Chiang Mai, ThailandChiang Mai University
Nov 20, 2023
Rectal Tumors Trial in Worldwide (radiation, device, drug)
Active, not recruiting
- Rectal Neoplasms
- 3D conformal EBRT
- +2 more
-
Aarhus, Denmark
- +19 more
Oct 18, 2022
Sars-CoV-2 Infection Trial in Negrar (Nasal and mouth swab)
Active, not recruiting
- Sars-CoV-2 Infection
- Nasal and mouth swab
-
Negrar, Verona, ItalyIRCCS Sacro Cuore Don Calabria hospital
Mar 14, 2023
ive Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Active, not recruiting
- Diabetes
- Semaglutide
- DPP-4 inhibitor
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 3, 2023
Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Trial in Canada, United States (BOTOX, Placebo for BOTOX)
Recruiting
- Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
- BOTOX
- Placebo for BOTOX
-
Homewood, Alabama
- +39 more
Jan 25, 2023
Very Low Birth Weight Infant, Bronchopulmonary Dysplasia Trial in Calgary (n3-LCPUFA enriched Intravenous Lipid Emulsion)
Recruiting
- Very Low Birth Weight Infant
- Bronchopulmonary Dysplasia
- n3-LCPUFA enriched Intravenous Lipid Emulsion
-
Calgary, Alberta, CanadaFoothills Medical Centre
Nov 4, 2022
Primary Open Angle Glaucoma, Cataract Trial in Fort Collins, Batavia, Maryville (CyPass Micro-Stent)
Recruiting
- Primary Open Angle Glaucoma
- Cataract
- CyPass Micro-Stent
-
Fort Collins, Colorado
- +2 more
May 2, 2022
High Blood Sugar, Metabolic Syndrome Trial (ANKASCIN 568-P Red yeast rice capsules, Placebo Capsules)
Not yet recruiting
- High Blood Sugar
- Metabolic Syndrome
- ANKASCIN 568-P Red yeast rice capsules
- Placebo Capsules
- (no location specified)
Feb 10, 2023
Intracerebral Hemorrhage Trial in Guangzhou (Chinese herbal medicine FYTF-919)
Not yet recruiting
- Intracerebral Hemorrhage
- Chinese herbal medicine FYTF-919
-
Guangzhou, Guangdong, ChinaGuangdong Province Hospital of Chinese Medicine
Aug 7, 2022
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States
Completed
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- Placebo
-
Birmingham, Alabama
- +96 more
Jul 21, 2022
Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)
Recruiting
- Multiple Sclerosis
- 18F-florbetaben PET/CT
-
Pavia, PV, ItalyICS Maugeri SpA SB IRCCS
Mar 23, 2023
Diabetes, Type 2 Trial in Japan (Empagliflozin, Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Empagliflozin
- Placebo
-
Aichi, Nagoya, Japan
- +17 more
Aug 23, 2022
SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)
Recruiting
- SCLC
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Transplant Trial in United States (OCS Heart System)
Recruiting
- Transplant
- OCS Heart System
-
Los Angeles, California
- +10 more
Jun 16, 2022
Dry Eye Disease Trial in Boston (OC-01 (varenicline) nasal spray, Placebo (vehicle control) nasal spray)
Completed
- Dry Eye Disease
- OC-01 (varenicline) nasal spray
- Placebo (vehicle control) nasal spray
-
Boston, MassachusettsTufts
Nov 30, 2021
Acute Respiratory Failure, Pulmonary Fibrosis Trial in Brazil (High Flow Nasal Catheter, Noninvasive positive pressure
Terminated
- Acute Respiratory Failure
- Pulmonary Fibrosis
- High Flow Nasal Catheter
- Noninvasive positive pressure ventilation (NIPPV)
-
Brasília, DF, Brazil
- +5 more
Aug 9, 2021
Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,
Recruiting
- Kidney Transplant Recipients
- Liver Transplant Recipients
- Pfizer-BioNTech Bivalent COVID-19 Vaccine
- +3 more
-
San Diego, California
- +14 more
Oct 31, 2022
Non-small Cell Lung Carcinoma Trial in China (Almonertinib, Pemetrexed, Cisplatin)
Enrolling by invitation
- Non-small Cell Lung Carcinoma
- Almonertinib
- +2 more
-
Beijing, Beijing, China
- +33 more
Feb 8, 2022
Premenstrual Syndrome, Aromatherapy Trial in Konya (Aromatherapy)
Not yet recruiting
- Premenstrual Syndrome
- Aromatherapy
- Aromatherapy
-
Konya, TurkeyKTO Karatay University
Dec 28, 2022
People Living With Chronic Pain
Not yet recruiting
- Chronic Pain; Exercise
- Focus group
- (no location specified)
Jun 20, 2023
Heart Failure Trial (Ponsegromab low dose, Ponsegromab medium dose, ponsegromab high dose)
Not yet recruiting
- Heart Failure
- Ponsegromab low dose
- +3 more
- (no location specified)
Aug 5, 2022
Autism Spectrum Disorder Trial in Chicago (Glutathione)
Enrolling by invitation
- Autism Spectrum Disorder
-
Chicago, IllinoisThe University of Chicago Medicine
Jul 12, 2023